SCHEMBL27722003

SCHEMBL27722003

Cc1cnc(Cl)nc1-c1cc2ccc(CC(C)(C)OC(N)=O)cc2s1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C9 P11712 1/20 0.33
NFKB1 P19838 1/20 0.33
CYP2C19 P33261 1/20 0.33
LMNA P02545 1/20 0.32
PMP22 Q01453 1/20 0.32
NLRP3 Q96P20 1/20 0.32
PDK1 Q15118 13/20 0.32
MAPK1 P28482 1/20 0.32
FFAR1 O14842 1/20 0.31
PDK2 Q15119 2/20 0.31
PDK4 Q16654 2/20 0.31
HSP90AA1 P07900 1/20 0.31
JAK2 O60674 1/20 0.31
JAK3 P52333 1/20 0.31
ESR1 P03372 1/20 0.31
ESR2 Q92731 1/20 0.31
PDK3 Q15120 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3966588 0.74 MAPKAPK2 (0.39)
SCHEMBL3970210 0.74 NPC1 (0.41) NFKB1LMNAPDK1ESR1ESR2
SCHEMBL3962466 0.73 HDAC1 (0.48) LMNAMAPK1HSP90AA1
SCHEMBL28772826 0.73 IKBKB (0.38)
SCHEMBL3963142 0.71 HDAC6 (0.38) PDK1MAPK1PDK2PDK4HSP90AA1
SCHEMBL3968816 0.71 HDAC6 (0.43)
SCHEMBL3969215 0.71 ESR1 (0.38) ESR1ESR2
SCHEMBL27578810 0.69 ALDH1A1 (0.57) CYP3A4CYP1A2CYP2D6CYP2C9NFKB1
SCHEMBL3963838 0.69 PIK3CD (0.41) JAK2JAK3
SCHEMBL3970954 0.68 CYP2A6 (0.39) LMNAPDK1PDK2PDK4HSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101309918-B [4-(benzo[b]thiophen-2-yl)-pyrimidin-2-yl]-amine derivatives as ikk-beta inhibitors for the treatment of cancer and inflammatory diseases LILLY CO ELI 2010-12-29 CN disclosed
CN-101309918-A [4-(benzo[b]thiophen-2-yl)-pyrimidin-2-yl]-amine derivatives as ikk-beta inhibitors for the treatment of cancer and inflammatory diseases LILLY CO ELI (US) 2008-11-19 CN disclosed